| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |